Synopsys Beats and Raises — But the 42% Growth Is a Merger Calendar, Not a Surge in AI Orders

Synopsys (SNPS), the software company whose electronic design automation (EDA) tools are how essentially every advanced chip gets designed, reported its fiscal third quarter after Wednesday's close with headline-grade numbers: revenue of $2.477 billion, up just over 42% from a year ago; non-GAAP earnings of $3.91 per share, above its own guidance of $3.63 to $3.69 and the $3.67 the Street expected; and another raise to fiscal 2026 targets, to $9.715 billion of revenue and $15.07 of non-GAAP EPS at the midpoint. Management says AI is driving "unprecedented complexity" in next-generation chip design, and that will be the read of this quarter you see everywhere.

Hold the 42% before accepting it, because of a window in the calendar. The company this quarter is being compared with did not exist a year ago: Synopsys closed its roughly $35 billion acquisition of simulation-software maker Ansys on July 17, 2025 — two weeks before the year-ago quarter even ended. A beat is real, but the growth on top of it is a merger arithmetic problem, not a straight read on AI demand.

To see what is inside the number, separate the two businesses. Chip designers use Synopsys' EDA software for synthesis, place-and-route and verification — the tools that turn a design into a manufacturable chip, which is why the stock is lumped in with the AI hardware complex. Ansys sold simulation software — structural, thermal, electromagnetic — to people building cars, aircraft and industrial machinery, a different customer base. The merger turned Synopsys into a roughly $9.7 billion engineering-software company in which about a third of revenue now comes from simulation rather than chip design.

Now do the comparison arithmetic. Last year's fiscal Q3 included something like $90 million of Ansys — the two-week stub between the July 17 close and July 31 year-end, the leftover after Ansys contributed $667.7 million to fiscal Q4 2025 and $756.6 million to the full year. This year's Q3 carries a full three months of Ansys, a business Synopsys now expects to contribute about $2.96 billion of the current fiscal year's revenue. Work the subtraction: a full Ansys quarter is on the order of $650 million to $700 million, so the legacy business inside today's $2.477 billion prints near $1.8 billion, against roughly $1.65 billion a year ago. That puts organic growth in the high single digits — essentially the ~8% core EDA growth rate the company itself acknowledged in May, which the market treated as a disappointment at the time.

That decomposition is the whole argument. The headline 42% fuses two very different truths: a merger that immediately expanded the revenue base by a third, and a core business compounding in the high single digits with real but more modest AI tailwinds. Q3 does carry genuine non-merger signals — Design IP returned to year-over-year growth after a soft spell, EDA was called an outperformer, Ansys had a strong quarter, and product backlog stood at $11.4 billion entering fiscal 2026, more than a year of revenue. But those confirm a durable compounder; they do not describe a business suddenly accelerating.

This distinction is not academic, because the market priced it once already, and recently. In late May Synopsys delivered an almost identical beat-and-raise and the shares fell 8.7% the next day, then slid about 21% over the summer to roughly $400 by late August, even as analysts kept lifting their targets. The trigger was exactly the growth composition: the core EDA line grew slightly over 8%, below the double-digit reacceleration the stock had been paying for, and Chief Executive Sassine Ghazi used a June conference appearance to talk about durable compounding rather than faster growth. Add fresh export-control fear for China — about 16% of revenue — after Huawei unveiled a new AI chip-design approach, plus insider and fund selling, and the multiple compressed. Wednesday's beat and second straight quarterly raise therefore land on a stock that has already been marked down for a slower story.

So what actually changed in this quarter? Not the revenue narrative, which was already known. Two things moved. First, the earnings line is where the raise is concentrated: the full-year non-GAAP EPS midpoint has climbed from $14.42 at the start of the fiscal year to $15.07 now — about a 4.5% raise — built on cost synergies and an operating-margin expansion management has pointed to in excess of 300 basis points. That puts fiscal 2026 EPS up roughly 17% from the $12.91 reported for fiscal 2025, and that margin-led earnings growth, not organic reacceleration, is what the quarter really confirmed. Second, the company's identity: labeling Synopsys "AI chip design" undersells a franchise that earns roughly a third of its revenue from simulation software for cars, aircraft and physical AI — demand funded by different budgets than hyperscale compute. This is neither the pure-EDA reacceleration story the bulls once paid for nor the fading merger story; it is a broader engineering-software company at a de-rated multiple.

The valuation math at Wednesday's close near $409, a $78 billion market cap, comes to roughly 27 times the raised fiscal 2026 non-GAAP EPS guide. The trailing GAAP P/E of around 86 looks alarming until you see why: acquisition accounting — chiefly amortization of the Ansys intangibles — is why reported GAAP earnings swung from $0.09 a share two quarters ago to $2.84 this quarter. The non-GAAP line is the more honest measure of the operating business. After the summer's de-rating, analysts' average target still sits near $560, about a third above the August quote.

The raise itself is back-loaded, and that is the number to watch. Arithmetic on the raised midpoints implies a fiscal Q4 of roughly $2.55 billion of revenue and about $4.04 of non-GAAP EPS — a record quarter and a step-up from the $3.91 just delivered. One quarter's print is a short horizon, though, and will not by itself re-rate the stock. The deciding observable is the organic growth line: whether the $11.4 billion backlog converts into core growth that returns toward the low double digits as customers put Synopsys' AI agents into their design flows at a scale the company can monetize. Synopsys has scheduled an investor day for September, and that is where management will have to defend the growth algorithm that a ~27 multiple no longer requires to be heroic. Between the back-loaded raise, a quarter whose growth is more merger calendar than AI acceleration, and an export-control regime for China that the company's own guidance assumes will not tighten further, Wednesday's beat is a confirmation of execution — not new evidence that the reacceleration the stock once sold for has arrived.